InvestorsHub Logo
Followers 224
Posts 32092
Boards Moderated 4
Alias Born 10/10/2005

Re: Fress post# 1380

Sunday, 06/06/2021 9:07:04 AM

Sunday, June 06, 2021 9:07:04 AM

Post# of 1582
PDS Biotechnology (NASDAQ:PDSB) had its price target raised by analysts at HC Wainwright from $8.00 to $20.00 on Wednesday. They now have a "buy" rating on the stock. They noted that the move was a valuation call.This represents a 56.5% upside from the current price of $12.78.

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PDSB News